Adding value to your assets, our aim
Our aim
- Finding a use for existing advanced small molecules in the therapeutic treatment of atopic dermatitis, psoriasis, actinic keratosis, acne, and related dermatological diseases.
- We are looking for compounds addressing a specific target or pathway in a selective manner with a scientific rationale that supports their use on one or more indications of interest
- More specifically, Research compounds that have shown a good potency and an acceptable pharmacokinetic profile or Development compounds that have shown a good human safety profile
Our partners
- Universities
- Research Centers
- Start-ups
- Biotechs
- Pharmaceutical companies
world-wide with an interest in pharmaceutical R&D
You benefits
- Biological profiling of your small molecule on key dermatological assays in vitro and in vivo
- Opportunity for an eventual long-term collaboration with us beyond the initial project
- Your intellectual property rights are protected
- No need to disclose the chemical structure of your compound
- All data and results generated will be treated as strictly confidential and will only be used to decide about future collaboration options
- You will be the owner of the results obtained
- We expect you not to patent, register, or communicate to any third party the results we generated whilst we are collaborating
- A specific contact person to help you with any questions will be available at any tim
Collaboration process
- Submit your proposal
- As an initial step, you should create an account in AlmirallShare Innovation platform, a secure tool to keep and manage your proposals
- You can submit your proposal at any time
- All the initial information provided under the proposal should be non-confidential. Please do not reveal the chemical structure of your compound, even if it is published
- Please include an outline of your proposal (max. 300 words) and a detailed description of your advanced compound properties, including at least biological data such as target and affinities (IC50, Ki…etc), and available ADME data
- Proposal evaluation
- A team of Almirall scientific experts will evaluate your proposal
- The evaluation process will have a duration of 4-6 weeks after proposal submission
- Proposal selection
- After the evaluation period, you will receive Almirall’s decision regarding the progression of your proposal
- Collaboration starts
- If your proposal has been selected, we will help you to draft a Material Transfer Agreement (MTA)
- Compounds will be tested in a pre-agreed panel of relevant cellular assays and in vivo disease models within a period of 4-6 months, starting upon MTA signature. This panel could be complemented with other assays, such as physicochemical properties and pharmacokinetic studies

For Universities, Research Centers, Start-ups, Biotechs and Pharma companies

Submit your proposal at any time